套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-23-227619 Act: 33 Size: 508 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-23-227626 Act: 34 Size: 464 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-095334 Act: 34 Size: 84 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-039830 Act: 34 Size: 8 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-039769 Act: 34 Size: 570 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0000950170-23-032992 Act: 34 Size: 244 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-032707 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002032 Act: 33 Size: 1 KB 网页链接
$Lyra Therapeutics(LYRA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-23-183840 Act: 33 Size: 256 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031862 Size: 5 KB 网页链接